4//SEC Filing
Johnson David Michael 4
Accession 0001725160-23-000146
CIK 0001725160other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:04 PM ET
Size
5.1 KB
Accession
0001725160-23-000146
Insider Transaction Report
Form 4
Johnson David Michael
Director
Transactions
- Award
Common Stock
2023-06-16+19,059→ 127,389 total
Footnotes (1)
- [F1]Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2024 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001808098
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:04 PM ET
- Size
- 5.1 KB